Dialysis industry news

Stories from the dialysis comunity across the globe.



DaVita Healthcare (DVA) Earnings Report: Q2 2015 Conference Call Transcript - TheStreet.com PDF Print

DaVita Healthcare (DVA) Earnings Report: Q2 2015 Conference Call Transcript
TheStreet.com
Re-admission rate 31% better than the US ESRD average and as low as 5% catheter rates in our special needs plans. Less than one-half are already industry-leading Company-wide rate and 70% better than the US ESRD average. These are wonderfully ...
Brokerage Perspectives on DaVita healthCare Partners Inc. (NYSE:DVA) Markets Daily
DaVita HealthCare Partners (DVA) Posts Quarterly Earnings Results, Hits Estimates Dakota Financial News

all 14 news articles »

...

 
TMAO Implicated As a Cardiovascular Risk Factor in CKD - Renal and Urology News PDF Print
August 05, 2015 TMAO Implicated As a Cardiovascular Risk Factor in CKD - Renal and Urology News
As renal function declines, levels of trimethylamine-N-oxide increase, and this correlates with increased atherosclerosis burden.

Prior studies in rodents have demonstrated trimethylamine-N-oxide (TMAO) to be a direct promoter of atherosclerosis. Patients with chronic kidney disease (CKD) exhibit accelerated development of atherosclerosis that contributes to the high cardiovascular mortality in this group. According to a new study performed by a research team led by Jason R. Stubbs, MD, of the University of Kansas Medical Center in Kansas City, CKD patients have elevated serum concentrations of TMAO that correlate with increased coronary atherosclerosis burden.

“Based on evidence that TMAO production is dependent on dietary precursors and the intestinal microbiome,” Dr. Stubbs' group concluded in a report published online ahead of print in the Journal of the American Society of Nephrology, “TMAO may represent a novel modifiable risk factor and therapeutic target for reducing cardiovascular mortality in patients with CKD.”

Intestinal bacteria metabolize dietary L-carnitine and choline to trimethylamine, which is then oxidized via hepatic flavin monooxygenase enzymes to form TMAO, the authors explained.

Previous studies have demonstrated an association between elevated TMAO levels and cardiovascular events in humans with preserved kidney function, “providing solid clinical evidence to support a link between TMAO and cardiovascular pathology.” No studies have examined the relationship between TMAO and atherosclerosis in CKD patients.

Dr. Stubbs and his colleagues measured serum concentrations and urinary excretion of TMAO in a cohort of 104 CKD patients and examined the effect of renal transplantation in 6 of these patients. In addition, the researchers examined the relationship between serum TMAO and coronary atherosclerosis burden, as well as overall mortality, in a separate cohort of 220 CKD patients undergoing coronary angiography.

Study results showed a strong inverse association between serum TMAO and estimated glomerular filtration rate. TMAO concentrations were significantly higher in dialysis-dependent patients compared with healthy controls (median 94.4 vs. 3.3 µM). In the 6 renal transplant recipients, TMAO concentrations declined significantly from 71.2 µM pre-transplant to 11.4 µM post-transplant, Dr. Stubbs' group reported.  Furthermore, the researchers observed a statistically significant and independent positive correlation between TMAO concentration and coronary atherosclerosis burden as defined by modified Gensini score. In addition, each 10 µM increment in TMAO concentration was associated with a 26% increase in long-term mortality risk independent of traditional cardiac risk factors.

“The current investigation advances our understanding of cardiovascular disease in CKD by providing a novel mechanistic link to explain the presence of accelerated atherosclerosis in patients with reduced kidney function,” the authors concluded. “As such, our study demonstrates a strong inverse relationship between circulating concentrations of TMAO, a novel atherogenic compound, and residual kidney function in patients with CKD, and defines TMAO as an independent predictor of coronary atherosclerosis in this population.”

...

 
Dialysis Clinic Inc. marks 17 years of service - Montrose Daily Press PDF Print
Dialysis Clinic Inc. marks 17 years of service

Dialysis Clinic Inc. marks 17 years of service

The new DCI Dialysis Center is hosting an open house Thursday.

 

Posted: Wednesday, August 5, 2015 2:00 am

Dialysis Clinic Inc. is hosting an open house at its new facility located at 846 South 5th St. from 4 p.m. to 6:30 p.m. Thursday, Aug. 6, as it celebrates 17 years of service to the city of Montrose.

The general public is invited to tour the facility, enjoy refreshments and participate in the ribbon cutting ceremony.

“DCI has a long-standing relationship with the community. We’re delighted to be able to offer our dialysis patients a new building that we believe will improve the patient experience,” said Dorothy Frantz, RN, nurse manager for DCI.

kAm%96 C646?E=J 3F:=E 724:=:EJ 3682? D6CG:?8 A2E:6?ED yF?6 aa] %96 ?6H 724:=:EJ @776CD A2E:6?ED 2 7=2E 6?EC2?46 7@C 62D:6C 2446DD E@ E96 3F:=5:?8[ 2 4@G6C65 A@CE:4@[ 2?5 2 3C:89E 2?5 2:CJ 2E>@DA96C6] t249 A2E:6?E DE2E:@? 92D :ED @H? 7=2E D4C66? %'[ 7C66 (:\u: 2446DD[ 2?5 2 ?6H 5:2=JD:D 492:C]k^Am kAm“tG6CJE9:?8 :D ?6H :?D:56 E96 srx |@?EC@D6 5:2=JD:D 724:=:EJ[ 6I46AE E96 DE277[” D2:5 uC2?EK]k^Am kAm%96 @A6? 9@FD6 :D 2? @AA@CEF?:EJ 7@C E96 4@>>F?:EJ E@ >66E E96 DE277 2?5 ?FCD6D] |65:42= 5:C64E@C[ y@D6A9 w2C2H:[ |s[ H:== 36 :? 2EE6?52?46[ 2=@?8 H:E9 E96 =@42= DE277 2?5 C6AC6D6?E2E:G6D 7C@> E96 srx 4@CA@C2E6 @77:46]k^Am kAm%9:D :D E96 7:CDE 6G6?E 2E E96 ?6H 724:=:EJ[ 2?5 E96 srx DE277 :D G6CJ 6I4:E65 E@ D9@H42D6 E96 ?6H 3F:=5:?8]k^Am kAm“(6’G6 4@>6 2 =@?8 H2J :? `f J62CD[” zC:DE:? r9:==6>:[ srx 25>:?:DEC2E@C[ D2:5] “x 9@A6 E96 4@>>F?:EJ H:== ;@:? FD @? %9FCD52J E@ D66 7@C E96>D6=G6D 9@H H@?56C7F= @FC ?6H 724:=:EJ C62==J :D]”k^Am kAm}@ #$'! :D ?646DD2CJ 7@C E9:D 6G6?E]k^Am kAm%96 `c\DE2E:@? 724:=:EJ @776CD :?\46?E6C 96>@5:2=JD:D |@?52J E9C@F89 $2EFC52J 7C@> f 2]>] E@ d A]>] srx |@?EC@D6 :D H6=4@>:?8 ?6H A2E:6?ED 2?5 2=D@ H6=4@>6D A2E:6?ED EC2G6=:?8 E@ E96 2C62 H9@ >2J ?665 5:2=JD:D]k^Am kAmu@C >@C6 :?7@C>2E:@?[ A=62D6 42== srx |@?EC@D6 2E Whf_X ac_\bb_a]k^Am

Subscription Required

An online service is needed to view this article in its entirety. You need an online service to view this article in its entirety.

Have an online subscription?

Login Now

Need an online subscription?

Subscribe

Login

Or, use your linked account:

Choose an online service.

Current print subscribers

...

 
Recent research into the dialysis market (hemodialysis peritoneal dialysis ... - WhaTech PDF Print

Recent research into the dialysis market (hemodialysis & peritoneal dialysis) global forecast to 2018 just published

The global dialysis market is broadly categorized into two segments, namely, hemodialysis (products & services) and peritoneal dialysis (products & services). The hemodialysis segment accounts for the larger share of the global market, while the peritoneal dialysis segment is expected to grow at a higher CAGR in the forecast period.

The Report on Global Dialysis Market studies relevant segments, region application, forecast CAGR growth, driving market factors, treatment advancements, key players, government initiatives, and it’s rooting in products and services over to 2018 period.

The hemodialysis (HD) products and services market includes machines, consumables, and services. The peritoneal dialysis (PD) products and services market includes concentrates/dialysates, cyclers, catheters, transfer sets, accessories, and PD services.

Moreover, the global market has also been classified on the basis of end users into in-center dialysis and home dialysis. The hemodialysis market is further segmented into center use HD and home HD.

The peritoneal dialysis market is segmented into continuous cycling peritoneal dialysis (CCPD), continuous ambulatory peritoneal dialysis (CAPD), intermittent PD, and PD Plus therapy. The in-center dialysis end users market includes hospitals and independent dialysis centers; whereas, the home dialysis end users market includes peritoneal dialysis end users and home hemodialysis end users.

Based on geography, the market is divided into North America, Asia-Pacific, Europe, and Rest of the World (RoW).

A number of factors such as the growing number of end stage renal disease patients and increasing prevalence of diabetes and hypertension are driving the growth of the dialysis market. In addition, factors such as low preference of patients for kidney transplantation, technological advancements, increase in private investment and venture funding to support the development of new products, and substantial government healthcare and medical expenditure on the treatment of end-stage renal disease are further stimulating the growth of the dialysis products and services market.

However, factors such as low awareness about kidney diseases and their treatment modalities (primarily in developing countries), reduction in Medicare reimbursements to dialysis centers, product recalls, and reuse of hemodialysis consumables (such as dialyzers and bloodlines) are restraining the growth of the dialysis market.

In 2013, North America holds the largest share in the global market, followed by Asia-Pacific, Europe, and RoW (Rest of the World). The Asia-Pacific region (comprising Japan, China, South Korea, India, and Rest of Asia-Pacific) is estimated to grow at the highest CAGR in the forecast period.

Factors such as the increasing number of independent dialysis centers, government initiatives to develop dialysis facilities, and increasing awareness about new dialysis treatment modalities are driving the growth of the market in the Asia-Pacific region.

The major players in the market include Fresno's Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (U.S.), Gambro AB (Sweden), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Nipro Corporation (Japan), Diaverum Deutschland GmbH (Germany), Medical Components, Inc. (U.S.), Nikkiso Co. Ltd. (Japan), and NxStage Medical, Inc. (U.S.).

Complete Report is available @

http://www.jsbmarketresearch.com/healthcare-medical/r-Dialysis-Market-Global-Forecast-to-2018-101526

Scope of the Report

This research report categorizes the global market into the following segments and sub-segments:

Global Hemodialysis Market, By Products and Services

Hemodialysis Services
In-center Hemodialysis services
Home Hemodialysis Services
Hemodialysis Products
Hemodialysis Machines
Center Use Hemodialysis Machines
Home Use Hemodialysis Machines
Hemodialysis Consumables/supplies
Dialyzers
Hemodialysis Access Products
Hemodialysis Bloodlines
Hemodialysis Concentrates/dialysates
Others
Global Peritoneal Dialysis Market, By Products and Services
Peritoneal Dialysis Products
Peritoneal Dialysis Concentrates/dialysates
Peritoneal Dialysis Machines
Peritoneal Dialysis Catheters
Peritoneal Dialysis Transfer Sets
Other
Peritoneal Dialysis Services
Global Dialysis Market, By Category
Hemodialysis
Center Use Hemodialysis
Home Hemodialysis
Peritoneal Dialysis
Continuous Cycling Peritoneal Dialysis (CCPD)
Continuous Ambulatory Peritoneal Dialysis (CAPD)
Intermittent PD (IPD)
PD Plus Therapy
Global Dialysis Market, By End Users
In-center Dialysis
Hospitals
Independent Dialysis Centers
Home Dialysis
Peritoneal Dialysis
Home Hemodialysis
Global Dialysis Market, by Geography
North America
Asia-Pacific
Europe
RoW (Rest of the World)

Table Of Contents

1 Introduction (Page No. - 26)

1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology

2 Executive Summary (Page No. - 37)

3 Market Overview (Page No. - 41)

3.1 Introduction
3.2 Evolution
3.3 Market Segmentation
3.3.1 Hemodialysis Market By Products & Services
3.3.2 Peritoneal Dialysis Market By Products & Services
3.3.3 Dialysis Market By Category

4 Industry Analysis (Page No. - 67)
4.1 Introduction
4.2 Supply Chain Analysis
4.3 Pricing And Cost Analysis

7 Global Dialysis Market, By Category (Page No. - 142)
7.1 Introduction
7.2 Hemodialysis Market
7.2.1 Center Use Hemodialysis Market
7.2.2 Home Hemodialysis Market 

...

 
Officals, board talk dialysis - International Falls Journal PDF Print

Staffing in the consultant’s business plan includes a doctor, director of nurses, home nurse and technician, the minutes said. Fritzch also said there is a push for legislation to allow doctors to use telemedicine to cover required dialysis patient care which helps in recruiting a physician to cover rural and more areas. But, this is not yet allowed in Minnesota, the minutes said.

...

 
<< Start < Prev 41 42 43 44 45 46 47 48 49 50 Next > End >>

Page 42 of 4210
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.